Your browser doesn't support javascript.
loading
SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial.
Inagaki, Nobuya; Onouchi, Hitoshi; Sano, Hiroki; Funao, Nobuo; Kuroda, Shingo; Kaku, Kohei.
Afiliação
  • Inagaki N; Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan. Electronic address: inagaki@metab.kuhp.kyoto-u.ac.jp.
  • Onouchi H; Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Sano H; Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Funao N; Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Kuroda S; Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited, Osaka, Japan.
  • Kaku K; Kawasaki Medical School, Okayama, Japan.
Lancet Diabetes Endocrinol ; 2(2): 125-32, 2014 Feb.
Article em En | MEDLINE | ID: mdl-24622716
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Aged / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article